SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-008376
Filing Date
2021-06-17
Accepted
2021-06-17 13:38:44
Documents
3
Period of Report
2021-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210614x8k.htm 8-K 34342
2 EX-2.1 tmb-20210614xex2d1.htm EX-2.1 635360
3 GRAPHIC tmb-20210614xex2d1002.jpg GRAPHIC 660
  Complete submission text file 0001558370-21-008376.txt   672004
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 211024172
SIC: 2836 Biological Products, (No Diagnostic Substances)